Activating proteins linked to longevity may help to increase endurance and combat frailty in the elderly.
As we get older, our endurance declines, in part because our blood vessels lose some of their capacity to deliver oxygen and nutrients to muscle tissue. An MIT-led research team has now found that it can reverse this age-related endurance loss in mice by treating them with a compound that promotes new blood vessel growth.
The study found that the compound, which re-activates longevity-linked proteins called sirtuins, promotes the growth of blood vessels and muscle, boosting the endurance of elderly mice by up to 80 percent.
If the findings translate to humans, this restoration of muscle mass could help to combat some of the effects of age-related frailty, which often lead to osteoporosis and other debilitating conditions.
“We’ll have to see if this plays out in people, but you may actually be able to rescue muscle mass in an aging population by this kind of intervention,” says Leonard Guarente, the Novartis Professor of Biology at MIT and one of the senior authors of the study. “There’s a lot of crosstalk between muscle and bone, so losing muscle mass ultimately can lead to loss of bone, osteoporosis, and frailty, which is a major problem in aging.”
The first author of the paper, which appears in Cell on March 22, is Abhirup Das, a former postdoc in Guarente’s lab who is now at the University of New South Wales in Australia. Other senior authors of the paper are David Sinclair, a professor at Harvard Medical School and the University of New South Wales, and Zolt Arany, a professor at the University of Pennsylvania.
Race against time
In the early 1990s, Guarente discovered that sirtuins, a class of proteins found in nearly all animals, protect against the effects of aging in yeast. Since then, similar effects have been seen in many other organisms.
In their latest study, Guarente and his colleagues decided to explore the role of sirtuins in endothelial cells, which line the inside of blood vessels. To do that, they deleted the gene for SIRT1, which encodes the major mammalian sirtuin, in endothelial cells of mice. They found that at 6 months of age, these mice had reduced capillary density and could run only half as far as normal 6-month-old mice.
The researchers then decided to see what would happen if they boosted sirtuin levels in normal mice as they aged. They treated the mice with a compound called NMN, which is a precursor to NAD, a coenzyme that activates SIRT1. NAD levels normally drop as animals age, which is believed to be caused by a combination of reduced NAD production and faster NAD degradation.
After 18-month-old mice were treated with NMN for two months, their capillary density was restored to levels typically seen in young mice, and they experienced a 56 to 80 percent improvement in endurance. Beneficial effects were also seen in mice up to 32 months of age (comparable to humans in their 80s).
“In normal aging, the number of blood vessels goes down, so you lose the capacity to deliver nutrients and oxygen to tissues like muscle, and that contributes to decline,” Guarente says. “The effect of the precursors that boost NAD is to counteract the decline that occurs with normal aging, to reactivate SIRT1, and to restore function in endothelial cells to give rise to more blood vessels.”
These effects were enhanced when the researchers treated the mice with both NMN and hydrogen sulfide, another sirtuin activator.
Vittorio Sartorelli, chief of the Laboratory of Muscle Stem Cells and Gene Regulation at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, who was not involved in the research, described the experiments as “elegant and compelling.” He added that “it will be of interest and of clinical relevance to evaluate the effect of NMN and hydrogen sulfide on the vascularization of other organs such as the heart and brain, which are often damaged by acutely or chronically reduced blood flow.”
Benefits of exercise
The researchers also found that SIRT1 activity in endothelial cells is critical for the beneficial effects of exercise in young mice. In mice, exercise generally stimulates growth of new blood vessels and boosts muscle mass. However, when the researchers knocked out SIRT1 in endothelial cells of 10-month-old mice, then put them on a four-week treadmill running program, they found that the exercise did not produce the same gains seen in normal 10-month-old mice on the same training plan.
If validated in humans, the findings would suggest that boosting sirtuin levels may help older people retain their muscle mass with exercise, Guarente says. Studies in humans have shown that age-related muscle loss can be partially staved off with exercise, especially weight training.
“What this paper would suggest is that you may actually be able to rescue muscle mass in an aging population by this kind of intervention with an NAD precursor,” Guarente says.
The Latest on: Age-related frailty
via Google News
The Latest on: Age-related frailty
- Age, Sex and Overall Health, Measured As Frailty, Modify Myofilament Proteins in Hearts From Naturally Aging Miceon June 22, 2020 at 3:22 am
We investigated effects of age, sex and frailty on contractions, calcium transients and myofilament proteins to determine if maladaptive changes associated with aging were sex-specific and modified by ...
- Osteoarthritis and Frailty in Elderly Individuals Across Six European Countrieson June 12, 2020 at 5:00 pm
Because OA occurs in older adults who also have age-related changes in muscle ... study was to consider the association between OA and frailty/pre-frailty in an elderly population comprised ...
- Cool Tech for Your Workoutson June 11, 2020 at 5:00 pm
Until I started using the device a year ago, I felt I was only slowing my descent into age-related frailty. It was a fight I took seriously, but slow failure is not fun. Since integrating this ...
- Regular physical activity can maintain or improve frailtyon June 11, 2020 at 1:18 pm
Frailty is the medical term for becoming weaker or experiencing lower levels of activity or energy. Becoming frail as we age increases our risk for poor health, falls, disability, and other ...
- T cells with dysfunctional mitochondria induce multimorbidity and premature senescenceon June 6, 2020 at 5:00 pm
An age-related decline in mitochondrial function has been observed ... In humans, inflammaging predicts susceptibility to cardiovascular diseases, neurodegeneration, frailty, and multimorbidity (14–16 ...
- Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cellson June 1, 2020 at 8:01 am
This is another key milestone for Longeveron's Aging Frailty program, which includes two ongoing Phase 2 clinical trials in the U.S. "We are extremely pleased to achieve this significant milestone ...
- MDI Biological Laboratory Scientist Receives Federal Grant to Study Agingon May 28, 2020 at 5:00 pm
The understanding of these mechanisms that will be gained from this research holds the prospect of contributing to new therapies to delay or offset the effects of age-related diseases ... health risks ...
- Older age and depression linked to frailty in cancer survivorson May 28, 2020 at 11:32 am
Cancer survivors of older age with comorbidities, depression and low mobility are more likely to suffer from frailty, finds a new study. Prevention strategies could help to lower frailty risk in ...
via Bing News